Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 317

1.

NCI Comparative Oncology Program Testing of Non-Camptothecin Indenoisoquinoline Topoisomerase I Inhibitors in Naturally Occurring Canine Lymphoma.

Burton JH, Mazcko CN, LeBlanc AK, Covey JM, Ji JJ, Kinders RJ, Parchment RE, Khanna C, Paoloni M, Lana SE, Weishaar K, London CA, Kisseberth WC, Krick E, Vail DM, Childress MO, Bryan JN, Barber LG, Ehrhart EJ, Kent MS, Fan TM, Kow KY, Northup N, Wilson-Robles H, Tomaszewski JE, Holleran JL, Muzzio M, Eiseman J, Beumer JH, Doroshow JH, Pommier Y.

Clin Cancer Res. 2018 Jul 30. pii: clincanres.1498.2018. doi: 10.1158/1078-0432.CCR-18-1498. [Epub ahead of print]

PMID:
30061364
2.

Novel antibody reagents for characterization of drug- and tumor microenvironment-induced changes in epithelial-mesenchymal transition and cancer stem cells.

Navas T, Pfister TD, Colantonio S, Aziz A, Dieckman L, Saul RG, Kaczmarczyk J, Borgel S, Alcoser SY, Hollingshead MG, Lee YH, Bottaro DP, Hiltke T, Whiteley G, Takebe N, Kinders RJ, Parchment RE, Tomaszewski JE, Doroshow JH.

PLoS One. 2018 Jun 21;13(6):e0199361. doi: 10.1371/journal.pone.0199361. eCollection 2018.

3.

Automated erythrocyte detection and classification from whole slide images.

Govind D, Lutnick B, Tomaszewski JE, Sarder P.

J Med Imaging (Bellingham). 2018 Apr;5(2):027501. doi: 10.1117/1.JMI.5.2.027501. Epub 2018 Apr 10.

PMID:
29721517
4.

Outsourcing of Academic Clinical Laboratories: Experiences and Lessons From the Association of Pathology Chairs Laboratory Outsourcing Survey.

Mrak RE, Parslow TG, Tomaszewski JE.

Acad Pathol. 2018 Apr 2;5:2374289518765435. doi: 10.1177/2374289518765435. eCollection 2018 Jan-Dec.

5.

Multi-radial LBP Features as a Tool for Rapid Glomerular Detection and Assessment in Whole Slide Histopathology Images.

Simon O, Yacoub R, Jain S, Tomaszewski JE, Sarder P.

Sci Rep. 2018 Feb 1;8(1):2032. doi: 10.1038/s41598-018-20453-7.

6.

Special Section Guest Editorial: Digital Pathology.

Gurcan MN, Tomaszewski JE, Madabhushi A.

J Med Imaging (Bellingham). 2017 Apr;4(2):021101. doi: 10.1117/1.JMI.4.2.021101. Epub 2017 Jun 28. No abstract available.

7.

Antibody-independent capture of circulating tumor cells of non-epithelial origin with the ApoStream® system.

Balasubramanian P, Kinders RJ, Kummar S, Gupta V, Hasegawa D, Menachery A, Lawrence SM, Wang L, Ferry-Galow K, Davis D, Parchment RE, Tomaszewski JE, Doroshow JH.

PLoS One. 2017 Apr 12;12(4):e0175414. doi: 10.1371/journal.pone.0175414. eCollection 2017.

8.

Unsupervised labeling of glomerular boundaries using Gabor filters and statistical testing in renal histology.

Ginley B, Tomaszewski JE, Yacoub R, Chen F, Sarder P.

J Med Imaging (Bellingham). 2017 Apr;4(2):021102. doi: 10.1117/1.JMI.4.2.021102. Epub 2017 Feb 28.

9.

Phosphorylated fraction of H2AX as a measurement for DNA damage in cancer cells and potential applications of a novel assay.

Ji J, Zhang Y, Redon CE, Reinhold WC, Chen AP, Fogli LK, Holbeck SL, Parchment RE, Hollingshead M, Tomaszewski JE, Dudon Q, Pommier Y, Doroshow JH, Bonner WM.

PLoS One. 2017 Feb 3;12(2):e0171582. doi: 10.1371/journal.pone.0171582. eCollection 2017.

10.

Indolo-pyrido-isoquinolin based alkaloid inhibits growth, invasion and migration of breast cancer cells via activation of p53-miR34a axis.

Avtanski DB, Nagalingam A, Tomaszewski JE, Risbood P, Difillippantonio MJ, Saxena NK, Malhotra SV, Sharma D.

Mol Oncol. 2016 Aug;10(7):1118-32. doi: 10.1016/j.molonc.2016.04.003. Epub 2016 May 20.

11.

Pharmacodynamic Response of the MET/HGF Receptor to Small-Molecule Tyrosine Kinase Inhibitors Examined with Validated, Fit-for-Clinic Immunoassays.

Srivastava AK, Hollingshead MG, Weiner J, Navas T, Evrard YA, Khin SA, Ji JJ, Zhang Y, Borgel S, Pfister TD, Kinders RJ, Bottaro DP, Linehan WM, Tomaszewski JE, Doroshow JH, Parchment RE.

Clin Cancer Res. 2016 Jul 15;22(14):3683-94. doi: 10.1158/1078-0432.CCR-15-2323. Epub 2016 Mar 21.

12.

Effect of a Smac Mimetic (TL32711, Birinapant) on the Apoptotic Program and Apoptosis Biomarkers Examined with Validated Multiplex Immunoassays Fit for Clinical Use.

Srivastava AK, Jaganathan S, Stephen L, Hollingshead MG, Layhee A, Damour E, Govindharajulu JP, Donohue J, Esposito D, Mapes JP, Kinders RJ, Takebe N, Tomaszewski JE, Kummar S, Doroshow JH, Parchment RE.

Clin Cancer Res. 2016 Feb 15;22(4):1000-10. doi: 10.1158/1078-0432.CCR-14-3156. Epub 2015 Oct 7.

13.

Computational Pathology: A Path Ahead.

Louis DN, Feldman M, Carter AB, Dighe AS, Pfeifer JD, Bry L, Almeida JS, Saltz J, Braun J, Tomaszewski JE, Gilbertson JR, Sinard JH, Gerber GK, Galli SJ, Golden JA, Becich MJ.

Arch Pathol Lab Med. 2016 Jan;140(1):41-50. doi: 10.5858/arpa.2015-0093-SA. Epub 2015 Jun 22.

14.

Proteasome inhibitors.

Teicher BA, Tomaszewski JE.

Biochem Pharmacol. 2015 Jul 1;96(1):1-9. doi: 10.1016/j.bcp.2015.04.008. Epub 2015 Apr 29.

15.

Notch1 phenotype and clinical stage progression in non-small cell lung cancer.

Nguyen D, Rubinstein L, Takebe N, Miele L, Tomaszewski JE, Ivy P, Doroshow JH, Yang SX.

J Hematol Oncol. 2015 Feb 6;8:9. doi: 10.1186/s13045-014-0104-2.

16.

Supervised multi-view canonical correlation analysis (sMVCCA): integrating histologic and proteomic features for predicting recurrent prostate cancer.

Lee G, Singanamalli A, Wang H, Feldman MD, Master SR, Shih NN, Spangler E, Rebbeck T, Tomaszewski JE, Madabhushi A.

IEEE Trans Med Imaging. 2015 Jan;34(1):284-97. doi: 10.1109/TMI.2014.2355175. Epub 2014 Sep 5.

PMID:
25203987
17.

Co-occurring gland angularity in localized subgraphs: predicting biochemical recurrence in intermediate-risk prostate cancer patients.

Lee G, Sparks R, Ali S, Shih NN, Feldman MD, Spangler E, Rebbeck T, Tomaszewski JE, Madabhushi A.

PLoS One. 2014 May 29;9(5):e97954. doi: 10.1371/journal.pone.0097954. eCollection 2014.

18.

Histostitcher™: An informatics software platform for reconstructing whole-mount prostate histology using the extensible imaging platform framework.

Toth RJ, Shih N, Tomaszewski JE, Feldman MD, Kutter O, Yu DN, Paulus JC Jr, Paladini G, Madabhushi A.

J Pathol Inform. 2014 Mar 28;5(1):8. doi: 10.4103/2153-3539.129441. eCollection 2014.

19.

Validation of a hypoxia-inducible factor-1 alpha specimen collection procedure and quantitative enzyme-linked immunosorbent assay in solid tumor tissues.

Park SR, Kinders RJ, Khin S, Hollingshead M, Antony S, Parchment RE, Tomaszewski JE, Kummar S, Doroshow JH.

Anal Biochem. 2014 Aug 15;459:1-11. doi: 10.1016/j.ab.2014.04.025. Epub 2014 May 4.

20.

Computerized image analysis for identifying triple-negative breast cancers and differentiating them from other molecular subtypes of breast cancer on dynamic contrast-enhanced MR images: a feasibility study.

Agner SC, Rosen MA, Englander S, Tomaszewski JE, Feldman MD, Zhang P, Mies C, Schnall MD, Madabhushi A.

Radiology. 2014 Jul;272(1):91-9. doi: 10.1148/radiol.14121031. Epub 2014 Mar 10.

21.
22.

Immunohistochemical studies of metastatic germ-cell tumors in retroperitoneal dissection specimens: a sensitive and specific panel.

Bai S, Wei S, Pasha TL, Yao Y, Tomaszewski JE, Bing Z.

Int J Surg Pathol. 2013 Aug;21(4):342-51. doi: 10.1177/1066896912471849.

PMID:
23893437
23.

Microsatellite instability and TARBP2 mutation study in upper urinary tract urothelial carcinoma.

Bai S, Nunez AL, Wei S, Ziober A, Yao Y, Tomaszewski JE, Bing Z.

Am J Clin Pathol. 2013 Jun;139(6):765-70. doi: 10.1309/AJCPBSLP8XHSWLOW.

PMID:
23690119
24.

Developing safety criteria for introducing new agents into neoadjuvant trials.

DeMichele A, Berry DA, Zujewski J, Hunsberger S, Rubinstein L, Tomaszewski JE, Kelloff G, Perlmutter J, Buxton M, Lyandres J, Albain KS, Benz C, Chien AJ, Haluska P, Leyland-Jones B, Liu MC, Munster P, Olopade O, Park JW, Parker BA, Pusztai L, Tripathy D, Rugo H, Yee D, Esserman L.

Clin Cancer Res. 2013 Jun 1;19(11):2817-23. doi: 10.1158/1078-0432.CCR-12-2620. Epub 2013 Mar 7. Review.

25.

Development and validation of an immunoassay for quantification of topoisomerase I in solid tumor tissues.

Pfister TD, Hollingshead M, Kinders RJ, Zhang Y, Evrard YA, Ji J, Khin SA, Borgel S, Stotler H, Carter J, Divelbiss R, Kummar S, Pommier Y, Parchment RE, Tomaszewski JE, Doroshow JH.

PLoS One. 2012;7(12):e50494. doi: 10.1371/journal.pone.0050494. Epub 2012 Dec 28.

26.
27.

MicroRNA expression profiles of seminoma from paraffin-embedded formalin-fixed tissue.

Bing Z, Master SR, Tobias JW, Baldwin DA, Xu XW, Tomaszewski JE.

Virchows Arch. 2012 Dec;461(6):663-8. doi: 10.1007/s00428-012-1325-9. Epub 2012 Oct 14.

PMID:
23064661
28.

Fluorescence in situ hybridization study of chromosome abnormalities of upper urinary tract urothelial carcinoma in paraffin-embedded tissue.

Bing Z, Li J, Master SR, Lee CC, Puthiyaveettil R, Tomaszewski JE.

Am J Clin Pathol. 2012 Sep;138(3):382-9. doi: 10.1309/AJCPUXAP6P2GVBTI.

PMID:
22912355
29.

Role of carbonic anhydrase IX, α-methylacyl coenzyme a racemase, cytokeratin 7, and galectin-3 in the evaluation of renal neoplasms: a tissue microarray immunohistochemical study.

Bing Z, Lal P, Lu S, Ziober A, Tomaszewski JE.

Ann Diagn Pathol. 2013 Feb;17(1):58-62. doi: 10.1016/j.anndiagpath.2012.07.002. Epub 2012 Aug 14.

PMID:
22898056
30.

Adsorption of insecticidal Cry1Ab protein to humic substances. 2. Influence of humic and fulvic acid charge and polarity characteristics.

Tomaszewski JE, Madliger M, Pedersen JA, Schwarzenbach RP, Sander M.

Environ Sci Technol. 2012 Sep 18;46(18):9932-40. doi: 10.1021/es302248u. Epub 2012 Aug 31.

PMID:
22862550
31.

Adsorption of insecticidal Cry1Ab protein to humic substances. 1. Experimental approach and mechanistic aspects.

Sander M, Tomaszewski JE, Madliger M, Schwarzenbach RP.

Environ Sci Technol. 2012 Sep 18;46(18):9923-31. doi: 10.1021/es3022478. Epub 2012 Aug 31.

PMID:
22862304
32.

The use of immunohistochemical expression of SF-1 and EMA in distinguishing adrenocortical tumors from renal neoplasms.

Enriquez ML, Lal P, Ziober A, Wang L, Tomaszewski JE, Bing Z.

Appl Immunohistochem Mol Morphol. 2012 Mar;20(2):141-5.

PMID:
22553814
33.

p53 in pure epithelioid PEComa: an immunohistochemistry study and gene mutation analysis.

Bing Z, Yao Y, Pasha T, Tomaszewski JE, Zhang PJ.

Int J Surg Pathol. 2012 Apr;20(2):115-22. doi: 10.1177/1066896912441829. Epub 2012 Mar 29.

PMID:
22459898
34.

Integration of architectural and cytologic driven image algorithms for prostate adenocarcinoma identification.

Hipp J, Monaco J, Kunju LP, Cheng J, Yagi Y, Rodriguez-Canales J, Emmert-Buck MR, Hewitt S, Feldman MD, Tomaszewski JE, Toner M, Tompkins RG, Flotte T, Lucas D, Gilbertson JR, Madabhushi A, Balis U.

Anal Cell Pathol (Amst). 2012;35(4):251-65. doi: 10.3233/ACP-2012-0054.

35.

Advances in using PARP inhibitors to treat cancer.

Kummar S, Chen A, Parchment RE, Kinders RJ, Ji J, Tomaszewski JE, Doroshow JH.

BMC Med. 2012 Mar 9;10:25. doi: 10.1186/1741-7015-10-25. Review.

36.

Accumulation of intrahepatic islet amyloid in a nonhuman primate transplant model.

Liu C, Koeberlein B, Feldman MD, Mueller R, Wang Z, Li Y, Lane K, Hoyt CC, Tomaszewski JE, Naji A, Rickels MR.

Endocrinology. 2012 Apr;153(4):1673-83. doi: 10.1210/en.2011-1560. Epub 2012 Feb 21.

37.

A phase I study of veliparib in combination with metronomic cyclophosphamide in adults with refractory solid tumors and lymphomas.

Kummar S, Ji J, Morgan R, Lenz HJ, Puhalla SL, Belani CP, Gandara DR, Allen D, Kiesel B, Beumer JH, Newman EM, Rubinstein L, Chen A, Zhang Y, Wang L, Kinders RJ, Parchment RE, Tomaszewski JE, Doroshow JH.

Clin Cancer Res. 2012 Mar 15;18(6):1726-34. doi: 10.1158/1078-0432.CCR-11-2821. Epub 2012 Feb 3.

38.

Supervised regularized canonical correlation analysis: integrating histologic and proteomic data for predicting biochemical failures.

Golugula A, Lee G, Master SR, Feldman MD, Tomaszewski JE, Madabhushi A.

Conf Proc IEEE Eng Med Biol Soc. 2011;2011:6434-7. doi: 10.1109/IEMBS.2011.6091588.

PMID:
22255811
39.

Image microarrays (IMA): Digital pathology's missing tool.

Hipp J, Cheng J, Pantanowitz L, Hewitt S, Yagi Y, Monaco J, Madabhushi A, Rodriguez-Canales J, Hanson J, Roy-Chowdhuri S, Filie AC, Feldman MD, Tomaszewski JE, Shih NN, Brodsky V, Giaccone G, Emmert-Buck MR, Balis UJ.

J Pathol Inform. 2011;2:47. doi: 10.4103/2153-3539.86829. Epub 2011 Oct 29.

40.

Supervised regularized canonical correlation analysis: integrating histologic and proteomic measurements for predicting biochemical recurrence following prostate surgery.

Golugula A, Lee G, Master SR, Feldman MD, Tomaszewski JE, Speicher DW, Madabhushi A.

BMC Bioinformatics. 2011 Dec 19;12:483. doi: 10.1186/1471-2105-12-483.

41.

Poly(ADP-ribose) polymerase inhibition enhances p53-dependent and -independent DNA damage responses induced by DNA damaging agent.

Nguyen D, Zajac-Kaye M, Rubinstein L, Voeller D, Tomaszewski JE, Kummar S, Chen AP, Pommier Y, Doroshow JH, Yang SX.

Cell Cycle. 2011 Dec 1;10(23):4074-82. doi: 10.4161/cc.10.23.18170. Epub 2011 Dec 1.

42.

Modeling pharmacodynamic response to the poly(ADP-Ribose) polymerase inhibitor ABT-888 in human peripheral blood mononuclear cells.

Ji J, Kinders RJ, Zhang Y, Rubinstein L, Kummar S, Parchment RE, Tomaszewski JE, Doroshow JH.

PLoS One. 2011;6(10):e26152. doi: 10.1371/journal.pone.0026152. Epub 2011 Oct 10.

43.

Phase I study of PARP inhibitor ABT-888 in combination with topotecan in adults with refractory solid tumors and lymphomas.

Kummar S, Chen A, Ji J, Zhang Y, Reid JM, Ames M, Jia L, Weil M, Speranza G, Murgo AJ, Kinders R, Wang L, Parchment RE, Carter J, Stotler H, Rubinstein L, Hollingshead M, Melillo G, Pommier Y, Bonner W, Tomaszewski JE, Doroshow JH.

Cancer Res. 2011 Sep 1;71(17):5626-34. doi: 10.1158/0008-5472.CAN-11-1227. Epub 2011 Jul 27.

44.

Protein encapsulation by humic substances.

Tomaszewski JE, Schwarzenbach RP, Sander M.

Environ Sci Technol. 2011 Jul 15;45(14):6003-10. doi: 10.1021/es200663h. Epub 2011 Jun 16.

PMID:
21678916
45.

Short-term toxicity study of ST-20 (NSC-741804) by oral gavage in Sprague-Dawley rats.

Terse PS, Johnson JD, Hawk MA, Ritchie GD, Ryan MJ, Vasconcelos DY, Contos DA, Perrine SP, Peggins JO, Tomaszewski JE.

Toxicol Pathol. 2011 Jun;39(4):614-22. doi: 10.1177/0192623311406933. Epub 2011 May 10.

PMID:
21558467
46.

Institutional profile: Developing and evaluating new drugs for cancer treatment: perspectives from the US National Cancer Institute.

Trimble EL, Abrams JS, Ansher SS, Smith MA, Zwiebel JA, Tomaszewski JE.

Future Med Chem. 2010 Apr;2(4):555-9. doi: 10.4155/fmc.10.11. No abstract available. Erratum in: Future Med Chem. 2010 May;2(5):902.

47.

Association of HLA polymorphisms with post-transplant lymphoproliferative disorder in solid-organ transplant recipients.

Reshef R, Luskin MR, Kamoun M, Vardhanabhuti S, Tomaszewski JE, Stadtmauer EA, Porter DL, Heitjan DF, Tsai de E.

Am J Transplant. 2011 Apr;11(4):817-25. doi: 10.1111/j.1600-6143.2011.03454.x. Epub 2011 Mar 14.

48.

HistoStitcher(©): an interactive program for accurate and rapid reconstruction of digitized whole histological sections from tissue fragments.

Chappelow J, Tomaszewski JE, Feldman M, Shih N, Madabhushi A.

Comput Med Imaging Graph. 2011 Oct-Dec;35(7-8):557-67. doi: 10.1016/j.compmedimag.2011.01.010. Epub 2011 Mar 11.

49.

Repeat prostate biopsy and the incremental risk of clinically insignificant prostate cancer.

Resnick MJ, Lee DJ, Magerfleisch L, Vanarsdalen KN, Tomaszewski JE, Wein AJ, Malkowicz SB, Guzzo TJ.

Urology. 2011 Mar;77(3):548-52. doi: 10.1016/j.urology.2010.08.063. Epub 2011 Jan 7.

PMID:
21215436
50.

Supplemental Content

Loading ...
Support Center